Cajal Neuroscience is a Washington-based biotechnology company that develops and commercializes novel therapeutics for the treatment of neurodegenerative diseases.
Business Model:
Revenue: $1M
Employees: 51-200
Address: 1616 Eastlake Avenue E
City: Seattle
State: WA
Zip: 98102
Country: US
Cajal Neuroscience is a Washington-based biotechnology company that develops and commercializes novel therapeutics for the treatment of neurodegenerative diseases.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 11/2022 | Series A | 7 | $96M |
Alexandria Venture Investments Bristol Myers Squibb Dolby Family Ventures Evotec Lux Capital The Column Group Two Sigma Ventures Alexandria Venture Investments Bristol Myers Squibb Dolby Family Ventures Evotec Lux Capital The Column Group Two Sigma Ventures |
1/2020 | Seed | - | 1/2020 | Seed Round | 1 | - |
Lux Capital Lux Capital |
1/2020 | Seed | - |
Lux Capital Lux Capital |
1/2020 | Seed Round | 1 | - |
Lux Capital Lux Capital |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|